BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33567991)

  • 1. SRT1720 Pretreatment Promotes Mitochondrial Biogenesis of Aged Human Mesenchymal Stem Cells and Improves Their Engraftment in Postinfarct Nonhuman Primate Hearts.
    Zeng Z; Yu K; Hu W; Cheng S; Gao C; Liu F; Chen J; Kong M; Zhang F; Liu X; Wang J
    Stem Cells Dev; 2021 Apr; 30(7):386-398. PubMed ID: 33567991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRT1720 promotes survival of aged human mesenchymal stem cells via FAIM: a pharmacological strategy to improve stem cell-based therapy for rat myocardial infarction.
    Liu X; Hu D; Zeng Z; Zhu W; Zhang N; Yu H; Chen H; Wang K; Wang Y; Wang L; Zhao J; Zhang L; Wu R; Hu X; Wang J
    Cell Death Dis; 2017 Apr; 8(4):e2731. PubMed ID: 28383554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin increases mitochondrial OPA1 via GSK3-mediated OMA1 ubiquitination to enhance therapeutic effects of mesenchymal stem cell transplantation.
    Yang F; Wu R; Jiang Z; Chen J; Nan J; Su S; Zhang N; Wang C; Zhao J; Ni C; Wang Y; Hu W; Zeng Z; Zhu K; Liu X; Hu X; Zhu W; Yu H; Huang J; Wang J
    Cell Death Dis; 2018 May; 9(5):556. PubMed ID: 29748581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ISL1 overexpression enhances the survival of transplanted human mesenchymal stem cells in a murine myocardial infarction model.
    Xiang Q; Liao Y; Chao H; Huang W; Liu J; Chen H; Hong D; Zou Z; Xiang AP; Li W
    Stem Cell Res Ther; 2018 Feb; 9(1):51. PubMed ID: 29482621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment.
    Han XJ; Li H; Liu CB; Luo ZR; Wang QL; Mou FF; Guo HD
    Life Sci; 2019 Sep; 233():116740. PubMed ID: 31398416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirtuin 1 Stimulation Attenuates Ischemic Liver Injury and Enhances Mitochondrial Recovery and Autophagy.
    Khader A; Yang WL; Godwin A; Prince JM; Nicastro JM; Coppa GF; Wang P
    Crit Care Med; 2016 Aug; 44(8):e651-63. PubMed ID: 26963320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.
    Williams AR; Hatzistergos KE; Addicott B; McCall F; Carvalho D; Suncion V; Morales AR; Da Silva J; Sussman MA; Heldman AW; Hare JM
    Circulation; 2013 Jan; 127(2):213-23. PubMed ID: 23224061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1/2-SOD2 pathway.
    Zhang Z; Tan Y; Zhu L; Zhang B; Feng P; Gao E; Xu C; Wang X; Yi W; Sun Y
    Life Sci; 2019 Aug; 231():116554. PubMed ID: 31194992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirtuin 1 activation stimulates mitochondrial biogenesis and attenuates renal injury after ischemia-reperfusion.
    Khader A; Yang WL; Kuncewitch M; Jacob A; Prince JM; Asirvatham JR; Nicastro J; Coppa GF; Wang P
    Transplantation; 2014 Jul; 98(2):148-56. PubMed ID: 24918615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Large-Scale Investigation of Hypoxia-Preconditioned Allogeneic Mesenchymal Stem Cells for Myocardial Repair in Nonhuman Primates: Paracrine Activity Without Remuscularization.
    Hu X; Xu Y; Zhong Z; Wu Y; Zhao J; Wang Y; Cheng H; Kong M; Zhang F; Chen Q; Sun J; Li Q; Jin J; Li Q; Chen L; Wang C; Zhan H; Fan Y; Yang Q; Yu L; Wu R; Liang J; Zhu J; Wang Y; Jin Y; Lin Y; Yang F; Jia L; Zhu W; Chen J; Yu H; Zhang J; Wang J
    Circ Res; 2016 Mar; 118(6):970-83. PubMed ID: 26838793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of mesenchymal stem cells preconditioned with diazoxide, a mitochondrial ATP-sensitive potassium channel opener, promotes repair of myocardial infarction in rats.
    Cui X; Wang H; Guo H; Wang C; Ao H; Liu X; Tan YZ
    Tohoku J Exp Med; 2010 Feb; 220(2):139-47. PubMed ID: 20139665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
    Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
    Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol alleviates alveolar epithelial cell injury induced by hyperoxia by reducing apoptosis and mitochondrial dysfunction.
    Zhu X; Wang F; Lei X; Dong W
    Exp Biol Med (Maywood); 2021 Mar; 246(5):596-606. PubMed ID: 33215523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRTUIN 1 ACTIVATOR SRT1720 PROTECTS AGAINST ORGAN INJURY INDUCED BY INTESTINAL ISCHEMIA-REPERFUSION.
    Hansen LW; Khader A; Yang WL; Prince JM; Nicastro JM; Coppa GF; Wang P
    Shock; 2016 Apr; 45(4):359-66. PubMed ID: 26263437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SRT1720 induces mitochondrial biogenesis and rescues mitochondrial function after oxidant injury in renal proximal tubule cells.
    Funk JA; Odejinmi S; Schnellmann RG
    J Pharmacol Exp Ther; 2010 May; 333(2):593-601. PubMed ID: 20103585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
    Huang J; Zhang Z; Guo J; Ni A; Deb A; Zhang L; Mirotsou M; Pratt RE; Dzau VJ
    Circ Res; 2010 Jun; 106(11):1753-62. PubMed ID: 20378860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific Sirt1 Activator-mediated Improvement in Glucose Homeostasis Requires Sirt1-Independent Activation of AMPK.
    Park SJ; Ahmad F; Um JH; Brown AL; Xu X; Kang H; Ke H; Feng X; Ryall J; Philp A; Schenk S; Kim MK; Sartorelli V; Chung JH
    EBioMedicine; 2017 Apr; 18():128-138. PubMed ID: 28396013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue inhibitor of matrix metalloproteinase-3 or vascular endothelial growth factor transfection of aged human mesenchymal stem cells enhances cell therapy after myocardial infarction.
    Yao J; Jiang SL; Liu W; Liu C; Chen W; Sun L; Liu KY; Jia ZB; Li RK; Tian H
    Rejuvenation Res; 2012 Oct; 15(5):495-506. PubMed ID: 22950427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT1-PGC1α-NFκB Pathway of Oxidative and Inflammatory Stress during Trypanosoma cruzi Infection: Benefits of SIRT1-Targeted Therapy in Improving Heart Function in Chagas Disease.
    Wan X; Wen JJ; Koo SJ; Liang LY; Garg NJ
    PLoS Pathog; 2016 Oct; 12(10):e1005954. PubMed ID: 27764247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The caspase-8 shRNA-modified mesenchymal stem cells improve the function of infarcted heart.
    Liang Y; Lin Q; Zhu J; Li X; Fu Y; Zou X; Liu X; Tan H; Deng C; Yu X; Shan Z; Yuan W
    Mol Cell Biochem; 2014 Dec; 397(1-2):7-16. PubMed ID: 25060909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.